Pillstats
Rx only · Injection, Solution · Subcutaneous

Glatiramer Acetate

Brands: Copaxone · Glatopa · Glatiramer Acetate

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL03AX13
RxCUI (US)84375
US makers8 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$45.80$91.60$137.41$183.21Dec 2025Apr 2026Jul 2026
$136.544
Latest avg · Jul 22, 2026
+44%
Since Dec 17, 2025
8
Active US suppliers
31%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.7K3.4K5.1K6.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.4K
Rx · 2026 Q1
74K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Neuroscience, Inc.unknown3SUPPLYING
Ajenat Pharmaceuticals LLCunknown2SUPPLYING
Sandoz Incunknown2SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
Italfarmaco SpAunknown2SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown2SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 24, 2013
    RECALLRecall (Class II): Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syri…

    Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe. — Recalling firm: Teva Pharmaceuticals USA — Nationwide

  • Dec 5, 2012
    RECALLRecall (Class II): Copaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33 Alcohol Preps…

    Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide

  • May 18, 2012
    RECALLRecall (Class II): Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

    Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide